Skip to main content

Search form

Medicines for Malaria Venture

Developing antimalarials to save lives

  • Research & Development
    • MMV's pipeline of antimalarial drugs
    • R&D areas of work
      • Next-generation medicines
      • Products for key populations
    • Working with regulators
    • Information for scientists
      • Malaria online course
      • Global health compound design webinars
      • Call for proposals
      • TPPs & TCPs
      • Learning resources for scientists
    • Project of the year award
    • Computational chemistry
    • R&D challenges
  • Access
    • Products & projects
    • Antimalarial drug availability
    • Areas of work
      • Supporting introduction
      • Enhancing reach
      • Informing R&D
      • Gathering market intelligence
    • Antimalarial drug toolkits
      • Artesunate injection dosage & administration
      • Artesunate rectal capsules tool kit
      • Seasonal Malaria Chemoprevention tool kit
    • Access challenges
  • Partnering
    • The PDP model
    • Our partner network
    • Our donors
      • Current donors
      • Past donors
    • Donate to MMV
    • Intellectual property rights (IPR)
    • Clinical centre partners by country
  • Our impact
    • Milestones
    • Malaria stories from the field
    • Antimalarial drugs for children
    • Gender equity
    • Global health security
      • Antimicrobial resistance to antimalarials
      • Malaria and COVID-19
  • About us
    • What we do
      • An overview of our work
      • Our strategic focus
      • Our history
    • People & governance
      • Staff bios
      • Staff interviews
      • Board of Directors
      • MMV North America Board
      • Expert Scientific Advisory Committee
      • Access & Product Management Advisory Committee
      • Global Safety Board
    • Work with us
      • Jobs
      • RFPs/RFIs
    • Policies
    • Diversity at MMV
    • Funding and expenditure
    • FAQs
    • Contact us
  • Malaria & medicines
    • Definitions and symptoms
    • 5 species of Plasmodium parasites
    • Lifecycle of malaria parasite
    • Malaria facts & statistics
    • Malaria treatment
    • History of antimalarial drugs
  • Newsroom
    • News & Press Releases
    • Audio
      • Media interviews
      • Speaking of Malaria podcast
    • Films
    • Infographics
    • Interviews
    • Image slideshows
    • Publications
    • Events
  • MMV Open
    • The Global Health Priority Box
      • About the Global Health Priority Box
      • Supporting information
      • Request the Global Health Priority Box
      • Terms & conditions
    • Malaria Libre
      • Malaria Libre open innovation platform
      • Participate in Malaria Libre
      • Malaria Libre data repository
    • MMVSola
      • About MMVSola
    • Pandemic Response Box
      • About the Pandemic Response Box
      • Request the Pandemic Response Box
      • Supporting information
      • Terms & conditions
    • COVID Box
      • About the COVID Box
      • Supporting information
      • COVID Box terms and conditions
    • Archived projects
      • Pathogen Box
      • Malaria Box
    • MMV Open Team
    • Contact us
  • Home
  • Newsroom
  • News

News

Filter
All
R&D
Donors
General
Open source
Partner
Access & product management
308 found

MMV calls for action against counterfeit drugs

06 Jun 2006

New Alliance to Build African Capacity for Malaria Drug and Vaccine Research

24 Apr 2006

MMV swims 10 km in World Swim for Malaria

03 Dec 2005

Landmark study: malaria gets less than 1% of global health R&D investment

30 Oct 2005

Open Letter to Leaders of the G-8 Nations

17 Jun 2005

Nature publishes research paper, Identification of an antimalarial synthetic trioxolane drug development candidate

19 Aug 2004

Dr Pascoal Mocumbi, named High Representative of the European and Developing Countries Clinical Trials Partnership (EDTCP) by the European Commission

19 Jan 2004

Pfizer reports important research developments against malaria

26 Jun 2003

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

Follow us

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Subscribe

Previous newsletters

Contact us

  • Tel: +41 22 555 03 00

    • Message us
    • Office directions
© MMV 2023
Website by Manta Ray Media
  • Glossary
  • Disclaimer
  • Privacy
  • Sitemap